The use of corticosteroid therapy in refractory Kawasaki patients

被引：0
|
作者：
Sulaiman M. Al-Mayouf
机构：
[1] King Faisal Specialist Hospital and Research Center,Rheumatology Section, Department of Pediatrics, MBC
来源：
Clinical Rheumatology | 2004年 / 23卷
关键词：
Kawasaki disease; Methylprednisolone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We retrospectively reviewed four children with Kawasaki disease refractory to the standard therapy. Although three patients had unusual complications, all four responded to intravenous methylprednisolone. This therapy may be considered early in the treatment of selected cases of Kawasaki disease.
引用
收藏
页码：11 / 13
页数：2
相关论文
共 50 条
  • [21] Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease
    Kimura, Mitsuaki
    Harazaki, Masashi
    Fukuoka, Tetsuya
    Asakura, Isao
    Sakai, Hidemasa
    Kamimaki, Tsutomu
    Ohkawara, Ichiro
    Akiyama, Naoe
    Tsurui, Satoshi
    Iwashima, Satoru
    Shimomura, Masaki
    Morishita, Hideaki
    Meguro, Takaaki
    Seto, Shiro
    PEDIATRICS INTERNATIONAL, 2017, 59 (04) : 397 - 403
  • [22] The use of neutrophil-lymphocyte ratio for the prediction of refractory disease and coronary artery lesions in patients with Kawasaki disease
    Farias, Juan S.
    Villarreal, Enrique G.
    Savorgnan, Fabio
    Acosta, Sebastian
    Flores, Saul
    Loomba, Rohit S.
    CARDIOLOGY IN THE YOUNG, 2023, 33 (08) : 1409 - 1417
  • [23] Recurrent refractory Kawasaki disease
    P Costa Reis
    S Nativ
    A Starr
    L Imundo
    A Eichenfield
    Pediatric Rheumatology, 9 (Suppl 1)
  • [24] Plasma exchange and infliximab as a third-line therapy for refractory infantile Kawasaki disease
    Ansai, Hideto
    Masuda, Hiroshi
    Nakao, Hiro
    Nishimura, Nao
    Kubota, Mitsuru
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [25] Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease
    Jibiki, Toshiaki
    Kato, Izumi
    Shiohama, Tadashi
    Abe, Katsuaki
    Anzai, Satoshi
    Takeda, Nobue
    Yamaguchi, Ken-ichi
    Kanazawa, Masaki
    Kurosaki, Tomomichi
    PEDIATRICS INTERNATIONAL, 2011, 53 (05) : 729 - 735
  • [26] Long term Prognosis After Methylprednisolon pulse Combination Therapy For Refractory Kawasaki Disease
    Ebato, Takasuke
    Ogihara, Yoshihito
    Takanashi, Manabu
    Honda, Takashi
    Kimura, Sumito
    Ogata, Shohei
    Ishii, Masahiro
    CIRCULATION, 2015, 131
  • [27] Use of Adjunctive Therapy in Acute Kawasaki Disease in Latin America
    Fortuna-Reyna, Brenda
    Bainto, Emelia V.
    Ulloa-Gutierrez, Rolando
    Garrido-Garcia, Luis M.
    Estripeaut, Dora
    del Aguila, Olguita
    Gomez, Virgen
    Faugier-Fuentes, Enrique
    Mino-Leon, Greta
    Beltran, Sandra
    Cofre, Fernanda
    Chacon-Cruz, Enrique
    Saltigeral-Simental, Patricia
    Martinez-Medina, Lucila
    Duenas, Lourdes
    Luciani, Kathia
    Rodriguez-Quiroz, Francisco J.
    Camacho-Moreno, German
    Viviani, Tamara
    Alvarez-Olmos, Martha I.
    Marques, Heloisa Helena de Sousa
    Lopez-Medina, Eduardo
    Pirez, Maria C.
    Tremoulet, Adriana H.
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [28] Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease
    Takashi Inoue
    Shokei Murakami
    Kenji Matsumoto
    Akio Matsuda
    Pediatric Rheumatology, 18
  • [29] Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease
    Inoue, Takashi
    Murakami, Shokei
    Matsumoto, Kenji
    Matsuda, Akio
    PEDIATRIC RHEUMATOLOGY, 2020, 18 (01)
  • [30] Long term Prognosis After Methylprednisolon pulse Combination Therapy For Refractory Kawasaki Disease
    Ebato, Takasuke
    Ogihara, Yoshihito
    Takanashi, Manabu
    Honda, Takashi
    Kimura, Sumito
    Ogata, Shohei
    Ishii, Masahiro
    CIRCULATION, 2015, 131
12345